Vijaya Diagnostic to acquire P H Diagnostic for Rs. 134.65 Cr
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Five batches across four programs of Biocon Academy participated in the graduation ceremony
His most recent stint was with Danone India as its Managing Director
Laurus Synthesis receives Form 483 with 5 observations from USFDA
The product will be manufactured at Lupin's Pithampur facility in India
Receives registration of Valganciclovir powder for oral solution in Germany
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Subscribe To Our Newsletter & Stay Updated